Advertisement Peak Surgical wins marketing approval for surgery system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Peak Surgical wins marketing approval for surgery system

Peak Surgical announced that the FDA has granted the company 510(k) clearance to market its Peak surgery system for use in general surgery.

The Peak surgery system combines the Pulsar Generator, which supplies pulsed plasma radiofrequency energy, with the Peak PlasmaBlade 4.0, a low-temperature surgical cutting and coagulation tool. This tissue dissection system will be commercially available next month.

John Tighe, CEO of Peak Surgical, said: “With the introduction of the PlasmaBlade, general surgeons now have access to a single surgical tool that cuts tissue as precisely as a scalpel and controls bleeding as effectively as traditional electrosurgery without causing extensive collateral thermal damage to tissues.”